
Investors Face October Deadline in ARS Pharmaceuticals Class Action
A 23.9% single-day stock collapse following the delay of critical insurance coverage for the allergy medication neffy has triggered a class action lawsuit against ARS Pharmaceuticals. Investors who purchased shares between March 9 and June 24, 2026, now face an October 5 deadline to seek lead plaintiff status.




















